Copyright
©The Author(s) 2023.
World J Gastroenterol. Sep 7, 2023; 29(33): 4975-4990
Published online Sep 7, 2023. doi: 10.3748/wjg.v29.i33.4975
Published online Sep 7, 2023. doi: 10.3748/wjg.v29.i33.4975
Figure 6 Effect of rAAV-Angiotensin-converting enzyme 2 treatment on the expression of adenosine monophosphate activates protein kinases signaling pathway proteins and autophagy-related proteins in mouse liver tissues.
A: The expression levels of p-AMPK, AMPK and p-mTOR were detected by western blotting; B: The expression levels of autophagy markers Beclin-1, LC3I and LC3II were detected by western blotting; C-F: The relative protein levels in each group were analyzed using ImageJ. aP < 0.01 vs Control; bP < 0.05 vs CCl4; cP < 0.05 vs rAAV-ACE2 + CCl4; dP < 0.05 vs Control; eP < 0.01 vs CCl4; fP < 0.001 vs Control; gP < 0.001 vs CCl4. Rapa: Rapamycin; p-mTOR: p-mammalian target of rapamycin; AMPK: Adenosine monophosphate activates protein kinases; ACE2: Angiotensin-converting enzyme 2.
- Citation: Wu Y, Yin AH, Sun JT, Xu WH, Zhang CQ. Angiotensin-converting enzyme 2 improves liver fibrosis in mice by regulating autophagy of hepatic stellate cells. World J Gastroenterol 2023; 29(33): 4975-4990
- URL: https://www.wjgnet.com/1007-9327/full/v29/i33/4975.htm
- DOI: https://dx.doi.org/10.3748/wjg.v29.i33.4975